1. Home
  2. ABCL vs DEA Comparison

ABCL vs DEA Comparison

Compare ABCL & DEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • DEA
  • Stock Information
  • Founded
  • ABCL 2012
  • DEA 2011
  • Country
  • ABCL Canada
  • DEA United States
  • Employees
  • ABCL N/A
  • DEA N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • DEA Real Estate Investment Trusts
  • Sector
  • ABCL Health Care
  • DEA Real Estate
  • Exchange
  • ABCL Nasdaq
  • DEA Nasdaq
  • Market Cap
  • ABCL 772.9M
  • DEA 912.0M
  • IPO Year
  • ABCL 2020
  • DEA 2015
  • Fundamental
  • Price
  • ABCL $2.02
  • DEA $21.71
  • Analyst Decision
  • ABCL Strong Buy
  • DEA Hold
  • Analyst Count
  • ABCL 4
  • DEA 4
  • Target Price
  • ABCL $8.33
  • DEA $29.06
  • AVG Volume (30 Days)
  • ABCL 4.1M
  • DEA 559.0K
  • Earning Date
  • ABCL 05-08-2025
  • DEA 04-29-2025
  • Dividend Yield
  • ABCL N/A
  • DEA 5.73%
  • EPS Growth
  • ABCL N/A
  • DEA N/A
  • EPS
  • ABCL N/A
  • DEA 0.41
  • Revenue
  • ABCL $23,114,000.00
  • DEA $314,385,000.00
  • Revenue This Year
  • ABCL N/A
  • DEA $7.23
  • Revenue Next Year
  • ABCL $36.62
  • DEA $7.93
  • P/E Ratio
  • ABCL N/A
  • DEA $53.17
  • Revenue Growth
  • ABCL N/A
  • DEA 6.82
  • 52 Week Low
  • ABCL $1.89
  • DEA $19.33
  • 52 Week High
  • ABCL $4.20
  • DEA $36.31
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 40.97
  • DEA 52.20
  • Support Level
  • ABCL $1.97
  • DEA $20.63
  • Resistance Level
  • ABCL $2.08
  • DEA $22.19
  • Average True Range (ATR)
  • ABCL 0.10
  • DEA 0.52
  • MACD
  • ABCL 0.01
  • DEA 0.21
  • Stochastic Oscillator
  • ABCL 29.63
  • DEA 67.27

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About DEA Easterly Government Properties Inc.

Easterly Government Properties Inc is a real estate investment trust. It is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. The company generates all its revenue by leasing its properties to such agencies.

Share on Social Networks: